Related Experiment Video
Updated: May 12, 2026
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
[Decade of Hodgkin lymphoma: PET CT vs biopsy in single Academic Chilean Center]
Maximiliano Vergara1, Nicolás Triantafilo1, James Campbell1
1Departamento de Hematología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Insights
This study on Hodgkin Lymphoma (HL) in Chile found comparable treatment outcomes to international standards. Positron Emission Tomography-Computed Tomography (PET-CT) demonstrated superior diagnostic and staging performance over Bone Marrow Biopsy.
Area of Science:
- Hematology
- Oncology
- Medical Imaging
Background:
- Hodgkin Lymphoma (HL) is a significant hematological malignancy globally and in Chile.
- This study focuses on HL treatment within a Chilean academic setting.
Purpose of the Study:
- To present a decade of Hodgkin Lymphoma treatment experience from a Chilean academic center.
- To evaluate the diagnostic efficacy of PET-CT versus Bone Marrow Biopsy for HL staging.
Main Methods:
- Retrospective cohort study design.
- Analysis of treatment data and outcomes for 82 Hodgkin Lymphoma patients.
- Comparative assessment of PET-CT and Bone Marrow Biopsy performance.
Main Results:
- Progression-free survival rates were 88.6% for localized and 66.4% for advanced stages.
- PET-CT exhibited higher sensitivity for staging compared to Bone Marrow Biopsy.
- Patient cohort averaged 35 years old with a 1.9:1 male to female ratio.
Conclusions:
- Clinical outcomes for HL patients in this Chilean center align with international findings.
- PET-CT is a more effective diagnostic and staging tool than Bone Marrow Biopsy for Hodgkin Lymphoma.
Introduction:
Hodgkin Lymphoma (HL) is a prevalent hematological cancer in the world and Chile.
Objectives:
Show the experience of 10 years treating HL in a Chilean academic center. Additionally, it exposes the diagnostic performance of PET CT and Bone Marrow Biopsy.
Material And Methods:
We conducted a retrospective cohort study to collect data and outcomes of patients treated in our center.
Results:
82 patients were analyzed (Average age, 35 years old; the ratio between men and women was 1.9:1). Progression-free survival was 88.6% and 66.4% for localized and advanced stages, respectively. PET as a staging strategy had better sensitivity than Marrow Biopsy.
Conclusions:
The clinical results of the patients treated in this Chilean teaching center were comparable to the international literature. Additionally, PET CT proved to be a superior tool in diagnosis and staging compared to biopsy in our patients.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Related Concept Videos
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET